SpiroGen spirogen.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

The Spirogen group was founded in 2001 as a spin-out from several institutions including University College, London and partly funded by Cancer Research UK.The group has developed a novel class of highly potent cytotoxic warheads based on its proprietary pyrrolobenzodiazepines (PBDs), DNA minor groove binding agents, which bind and cross-link specific sites of DNA of the cancer cell. This blocks the cancer cells' division without distorting its DNA helix, thus potentially avoiding the common phe...Show all

The Spirogen group was founded in 2001 as a spin-out from several institutions including University College, London and partly funded by Cancer Research UK.The group has developed a novel class of highly potent cytotoxic warheads based on its proprie...Show all

Company (Acquired)

Phone: +44-(0)-20-7278-0555

Fax:

The QMB Innovation Centre

London, E1 2AX
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SpiroGen $16.5M Oct 15, 2013
Novalar Pharmaceuticals $58.5M Jul 7, 2010
National Packaging Systems $0M Jan 2, 1995
See all 40 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SpiroGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 40 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-dll3 antibody drug conjugates Feb 21, 2014 May 15, 2018 Patent
Pyrrolobenzodiazepines used to treat proliferative diseases Nov 06, 2013 Aug 15, 2017 Patent
Pyrrolobenzodiazepines and targeted conjugates Oct 12, 2012 Jul 12, 2016 Patent
Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases Nov 13, 2013 Jan 27, 2015 Patent
Axl antibody-drug conjugate and its use for the treatment of cancer Apr 28, 2014 Application
See all 7 patents